News
17d
Zacks Investment Research on MSNCVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs.
3d
Zacks Investment Research on MSNCVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?CVS Health CVS and The Cigna Group CI stand as two dominant forces in the U.S. diversified healthcare sector, commanding ...
This was the stock's fifth consecutive day of gains.
In this note, we discuss CVS’ stock performance, key takeaways from its recent results, and valuation. CVS stock has seen little change, moving slightly from levels of $70 in early January 2021 ...
The reported meeting signals potential changes to improve shareholder value after weak stock performance CVS Health Corp.'s stock rose 1.7% Monday after a report surfaced of a meeting between the ...
CVS remains a strong buy as the stock price is not matching the fundamental performance of the business at all. But we have to question if CVS is actually a great long-term investment with a wide ...
CVS also withdrew its 2024 profit forecast and advised investors against relying on the full-year guidance provided in August, citing higher medical cost pressures. Stock prices have dropped ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results